# BCN PEPTIDES

> BCN PEPTIDES is a VC fund in Mediona backing Medical, Biopharma and Life Science. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Mediona, Spain
- Total investments: 1
- Last investment: Feb 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bcn-peptides
- Website: http://www.bcnpeptides.com

BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Affirma Biotech | Affirma Biotech is a developer of host-directed drugs as broad-spectrum treatments for chronic and severe infectious diseases. The company utilizes host-directed therapy strategies to interfere with host cell factors that are required by a pathogen for replication or persistence. The company engages in the discovery and development of newanti-infective drugs via immunomodulation. | $1.9M | Venture - Series Unknown | Feb 01, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Capital Cell](https://shizune.co/investors/profile/capital-cell) — VC Fund, 1 deal together
- [GENESIS Biomed](https://shizune.co/investors/profile/genesis-biomed) — VC Fund, 1 deal together
- [Nara Capital](https://shizune.co/investors/profile/nara-capital-6ad8) — VC Fund, 1 deal together
- [Reig Jofre](https://shizune.co/investors/profile/reig-jofre) — VC Fund, 1 deal together
- [SeedBlink](https://shizune.co/investors/profile/seedblink) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Life Science Investors in Spain](https://shizune.co/investors/life-science-investors-spain)
- [Medical Investors in Spain](https://shizune.co/investors/medical-investors-spain)
- [Biotech VC Funds in Spain](https://shizune.co/investors/biotech-vc-funds-spain)
- [Medical VC Funds in Spain](https://shizune.co/investors/medical-vc-funds-spain)

## FAQ

### What does BCN PEPTIDES invest in?

BCN PEPTIDES invests primarily in Medical, Biopharma and Life Science startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BCN PEPTIDES last invest?

The most recent investment recorded for BCN PEPTIDES closed in Feb 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co